FDA grants swift approval to Cognoa’s digital device for autism diagnosis
pharmaphorum
JUNE 3, 2021
Cognoa says the artificial intelligence (AI) based device is the first to be authorised by the US regulator that can help doctors diagnose autism in primary care, and will be launched “in the coming months” At the moment, autism can be difficult to diagnose as there are no medical markers to confirm its presence.
Let's personalize your content